Skip to main content

Table 2 Patient and tumor characteristics of eligible studies

From: Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis

Author

Sample

Age

Male

Treatment

Type of Neck Dissection

T stage

N stage

Subsite

LNY

PN+

Ye [22]

93

Mean 56.9 (32 to 87)

98%

Surgery OR Surgery with (RT OR CRT)

Radical, Elective

T1 to T4

N0, N1, N2a/b/c, N3

Pyriform sinus, Posterior wall, Postcricoid region,

NA

Mean 3 (0 to 34)

Lo [15]

120

Mean 56 (35 to 89)

98%

Surgery OR Surgery with (RT OR CRT)

Bilateral, Unilateral

T1 to T4

N0, N1, N2a/b/c, N3

Pyriform sinus, Posterior pharyngeal wall, Postcricoid

NA

Mean 4

Suzuki [21]

46

Median 66

94%

Surgery OR Surgery with (RT OR CT OR CRT)

Extended radical, Modified Radical, Selective

T1 to T4

N1, N2

Priform sinus, Others

Median 59.5 (14 to 114)

Median 3 (1 to 15)

Joo [14]

105

Mean 61 (35 to 80)

97%

Surgery OR Surgery with (RT OR CRT)

Bilateral, Modified Radical, Radical, Selective

T1 to T4

N1 to N3

Pyriform sinus, Posterior pharyngeal wall, Postcricoid region

Median 54 (15 to 176)

Median 3 (1 to 31)

Hua [13]

81

Median 60 (36 to 80)

98%

Surgery OR Surgery with (RT OR CRT)

Bilateral, Unilateral

T1 to T4

N1 to N3

Pyriform sinus, Posterior wall, Postcricoid region

Median 47 (3 to 95)

Median 2 (0 to 17)

Yu [29]

279

Mean 57.8 (34 to 85)

93%

RT OR RT with (CRT OR ICT OR Surgery OR Surgery with CT)

Radical, Modified Radical, Selective

T1 to T4

N0 to N3

Pyriform sinus, Posterior wall, Postcricoid region

Median 20 (2 to 76)

Median 2.0 (0.5 to 22.0)

Wang [27]

916

Median 61 (35 to 93)

42%

Surgery OR Surgery with RT

NA

T1 to T4a/b, Tx

N1 to N3

Pyriform sinus, Posterior wall, Postcricoid region, Aryepiglottic fold, Overlapping lesion, Hypopharynx

Median 25 (1 to 90)

Median 2 (1 to 90)

Imre [19]

101

Mean 58.5 (41 to 79)

95%

Surgery OR Surgery with (RT OR CRT)

Radical, Modified Radical, Selective

T1 to T4

N1, N2a/b/c

Glottis, Supraglottis, Transglottis

Mean 41.8 (18 to 88)

Mean 2.9 (1 to 15)

Ryu [16]

71

Median 65 (35 to 79)

93%

Surgery OR Surgery with (RT OR CRT)

Bilateral, Modified Radical, Radical, Selective

T1 to T4

N0 to N2

Supraglottis, Glottis, Transglottis

Median 52 (11 to 153),

Median 4 (1 to 21)

Wang [28]

1963

NA

78%

Surgery OR

Surgery with RT

NA

T1 to T4a/b, Tx

N1 to N3

Glottis, Supraglottis, Subglottis, Laryngeal cartilage, Overlapping lesion, Larynx

Median 28 (1 to 90)

Median 2 (1 to 90)

Künzel [20]

202

Median 59 (36 to 86)

93.1%

Surgery OR Surgery with (RT OR CRT)

Unilateral or bilateral modified radical

T1 to T4

N1, N2a/b/c

Glottic,Supraglottic,Unspecified site of origin within the larynx

Median 27 (10 to 88)

Median 2 (1 to 19)

Choi [12]

141

Median 65 (33 to 78)

93.6%

Surgery OR Surgery with (RT OR CRT)

Radical, Selective

T1 to T5

N1 to N3

Larynx, Hypopharynx

Median 60 (11 to 161)

Median 1 (0 to 21)

Grasl [18]

79

Median 60 (41.6 to 83)

88.6%

Surgery OR Surgery with (RT OR CRT/IRT)

Radical, Modified Radical, Selective

T1 to T4

N0, N1, N2a/b/c, N3a/b/c

Larynx, Hypopharynx

Median ± SD

48.0 ± 23.8

NA

  1. NA Not available, RT Radiotherapy, CT Chemotherapy, CRT Chemoradiotherapy, IRT Radio-immune therapy, LNY Lymph node yield, PN+ Positive lymph node number